Phenol Formylation
Phenol Formylation
Phenol Formylation
COO
-
Scheme 1.24
48 49 50 51
52
Acylation of diethyl malonate 53 with an acid chloride using MgCl
2
-Et
3
N as base system
gives adducts 54 in excellent yields (Scheme 1.25).
55
This method was also used for
preparation of -oxo esters from ethyl malonate mono potassium salt and acid chlorides in
92-99% yields.
56
In 2002 Evans et al.
57
used MgCl
2
-Et
3
N in anti-aldol reactions of chiral N-
acyloxazolidinones 55a-d in the presence of chlorotrimethylsilane. The adducts 56a-d were
formed with high diastereoselectivity (up to 32:1 dr) (Scheme 1.26).
15
Stereoselective imine aldol reactions of N-cyclohexylimine 57 with aromatic aldehydes in
the presence of MgCl
2
-Et
3
N at -45
o
C were examined recently by Hayashi et al.;
58
high
yields of products were obtained consisting essentially of the erythro isomer (Scheme 1.27).
1.5 Aim of the Study
The overall aim of this study was to employ the ortho-formylation method reported by
Skattebl and co-workers
34,35
for synthesis of natural products and compounds of medicinal
interest.
Also, the environmentally benign conditions in the Casnati-Skattebl
27,28,34,35
ortho-
formylation reaction inspired us to develop one-pot methods for the synthesis of useful
starting materials like ortho-hydroxycinnamate esters, salicylamines, and salicylnitriles.
Natural products have played an eminent role in the discovery and development of new
drugs. Over half of the nearly 1000 small-molecule drugs introduced on the market over the
past two-three decades are either natural products or in some way related to natural
products.
59
Hence, it is still of great interest to synthesize natural products and submit them
to biological testing.
16
References
1. (a) Lehnert, W. Tetrahedron, 1972, 28, 663; (b) Nore, P.; Honkanen, E. J. Heterocyclic Chem.,
1980, 17, 985; (c) Meuly, W. C. Kirk-Othmer Encyclopedia of Chemical Technology, 3rd ed.; John
Wiley & Sons: New York, 1979; Vol. 7, pp 196906; (d) Tietze, L. F.; Beifuss, U. The
Knoevenagel Reaction. In Comprehensive Organic Synthesis, Trost, B. M.; Fleming, I.;
Heathcock, C. H., Eds.; Pergamon Press: Oxford, 1991; Vol. 2, pp 341394.
2. Burgstahler, A. W.; Worden, L. R. Org. Synth., 1966, 46, 28.
3. Okui, H.; Tsukamoto, Y.; Mio, S. Eur. Pat. Appl. EP 909751, 1999.
4. (a) Larrow, J. F.; Schaus, S. E.; Jacobsen, E. N. J. Am. Chem. Soc., 1996, 118, 7420; (b) Quan, R.
W.; Li, Z.; Jacobsen, E. N. J. Am. Chem. Soc., 1996, 118, 8156; (c) Punniyamurthy, T.; Madhava
Reddy, M.; Kalra, S. J. S.; Iqbal, J. Pure Appl. Chem., 1996, 68, 619.
5. (a) Shuttleworth, R.; Fielden, J. M.; Levin, D. Eur. Pat. Appl. EP 536960, 1993; (b) Levin, D. Eur.
Pat. Appl. EP 529870, 1993.
6. (a) Wynberg, H. Chem. Rev., 1960, 60, 169; (b) H. Wynberg, The Reimer-Tiemann Reaction. In
Comprehensive Organic Chemistry, Trost, B. M.; Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol.
2, pp 769775; (c) Meth-Cohn, O.; Stanforth, S. P. The Vilsmeier-Haack Reaction. In
Comprehensive Organic Chemistry, Trost, B. M.; Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol.
2, pp 777794.
7. (a) Olah, G. A.; Ohannasian, L.; Arvanaghi, M. Chem. Rev., 1987, 87, 671; (b) Aldabbagh, F.
Aldehydes: Aryl and Heteroaryl Aldehydes. In Comprehensive Organic Functional Group
Transformations II, Katritzky, A. R.; Taylor, R. J. K., Eds.; Elsevier Pergamon: Oxford, 2005;
Vol. 3, pp 113119.
8. Laird, T. Aromatic aldehydes. In Comprehensive Organic Chemistry, Stoddart, J. F., Ed.;
Pergamon: Oxford, 1979; Vol. 1, pp 11051160.
9. Willemse, J. A.; Bezuidenhoudt, B. C. B.; Holzapfel, C. W. Synthesis, 2006, 2543.
10. Weisse, L.; Neunteufel, R.; Strutz, H. Eur. Pat. Appl. EP 599148, 1994.
11. Vibhute, Y. B.; Lonkar, S. M.; Mokle, S. S.; Sayyed, M. A. Chemistry (Rajkot, India), 2006, 3,
209.
12. Ravichandran, R. J. Mol. Catal. A: Chem., 1998, 130, L205.
13. Luknitskii, F. I. Chem. Rev., 1975, 75, 259.
14. Armstrong, D. E.; Richardson, D. H. J. Chem. Soc., 1933, 496.
15. Duff, J. C. J. Chem. Soc., 1941, 547.
16. (a) Allen, C. F. H.; Leubner G. W. Org. Synth. Coll. Vol. 4; John Wiley & Sons: London, 1963,
866; (b) Larrow, J. F.; Jacobsen, E. N. Org. Synth. Coll. Vol. 10; John Wiley & Sons: London,
2004, 96.
17. Suzuki, Y.; Takahashi, H. Chem. Pharm. Bull., 1983, 31, 1751.
18. (a) Weidner-Wells, M. A.; Fraga-Spano, S. A. Synth. Commun., 1996, 26, 2775; (b) Micklatcher,
M. L.; Cushman, M. Synthesis, 1999, 1878.
19. Smith, W. E. J. Org. Chem., 1972, 37, 3972.
20. (a) Matsuda, T.; Murata, T. Ger. Offen. DE 2923805, 1979; (b) Formanek, K. Eur. Pat. Appl. EP
77279, 1983; (c) Virnig, M. J. Eur. Pat. Appl. EP 106653, 1984.
21. Casiraghi, G.; Casnati, G.; Puglia, G.; Sartori, G.; Terenghi, G. J. Chem. Soc., Perkin Trans. 1,
1980, 1862.
22. Sun, Y.; Tang, N. J. Mol. Catal. A: Chem., 2006, 255, 171.
17
23. (a) Bauer, K.; Moelleken, R.; Fiege, H.; Wedemeyer, K. Ger. Offen. US 4119671, 1977; (b)
Hormel, T. S.; Kirchhoff, P. M.; Muench, W. C.; Robbins, L. A. U.S. Pat. US 4205188, 1980; (c)
Gradeff, P. S.; Murayama, S. T. U.S. Pat. US 4351962, 1982.
24. (a) Gassman, P. G.; Amick, D. R. Tetrahedron Lett., 1974, 15, 3463; (b) Gassman, P. G.; Amick,
D. R. Tetrahedron Lett., 1974, 15, 889.
25. Zwanenburg, D. J.; Reynen, W. A. P. Synthesis, 1976, 624.
26. Anastas, P. T.; Warner, J. C. Green Chemistry, Theory and Practice; Oxford University Press:
Oxford, 2000; pp 7182.
27. Casnati, G.; Crisafulli, M.; Ricca, A. Tetrahedron Lett., 1965, 6, 243.
28. Casiraghi, G.; Casnati, G.; Cornia, M.; Pochini, A.; Puglia, G.; Sartori, G.; Ungaro, R. J. Chem.
Soc., Perkin Trans 1, 1978, 318.
29. Hayashi, M.; Miyamoto, Y.; Inoue, T.; Oguni, N. J. Org. Chem., 1993, 58, 1515.
30. Wang, R. X.; You, X. Z.; Meng, Q. J.; Mintz, E. A.; Bu, X. R. Synth. Commun., 1994, 24, 1757.
31. Aldred, R.; Johnston, R.; Levin, D.; Neilan, J. J. Chem. Soc., Perkin Trans. 1, 1994, 1823.
32. Azuma, S.; Hiramatsu, T. Jpn. Pat. JP 06087783, 1994.
33. (a) Azuma, S.; Hiramatsu, T. Jpn. Pat. JP 06056731, 1994; (b) Azuma, S.; Hiramatsu, T. Jpn. Pat.
JP 06056732, 1994.
34. Hofslkken, N. U.; Skattebl, L. Acta Chem. Scand., 1999, 53, 258.
35. Hansen, T. V.; Skattebl, L. Org. Synth., 2005, 82, 64.
36. Taran, F.; Renard, P. Y.; Bernard, H.; Mioskowski, C.; Frobert, Y.; Pradelles, P.; Grassi. J. J. Am.
Chem. Soc., 1998, 120, 3332.
37. (a) Stange, H.; Matschiner, H.; Mendow, E.; Schunke, D.; Nauwald, G. Ger. Pat. DD 289516,
1991; (b) Maggioni, P.; Minisci, F. Belg. Pat. BE 877911, 1979.
38. Crochemore, M.; Rochin, C. Eur. Pat. Appl. EP 300861, 1989.
39. Gross, H.; Rieche, A.; Matthey, G. Chem. Ber., 1963, 96, 308.
40. Christensen, H. Synth. Commun., 1975, 5, 65.
41. Kauch, M.; Hoppe, D. Synthesis, 2006, 1575.
42. Wang, Y.-b.; Tian, S.-j.; Li, S.-f. Huaxue Gongye Yu Gongcheng, 2007, 24, 32.
43. Cerveny, L.; Jenista, P.; Marhoul, A.; Ruziska, V. Chem. Techn., 1976, 28, 557.
44. (a) Gombar, V.; Kapoor , V. K.; Singh, H. Arzneim-Forsch., 1983, 33, 1226; (b) Watanabe, K.;
Takimoto, A.; Iwamura, H.; Fujita, T. Plant Cell Physiol., 1983, 24, 889; (c) Habicht, J.; Brune, K.
J. Pharm. Pharmacol., 1983, 35, 718.
45. Sharma, G. V. M.; Ilangovan, A.; Lavanya, B. Synth. Commun., 2000, 30, 397.
46. Bigi, F.; Conforti, M. L.; Maggi, R.; Sartori, G. Tetrahedron, 2000, 56, 2709.
47. Ziegler, G.; Haug, E.; Frey, W.; Kantlehner, W. Z. Naturforsch. B., 2001, 56, 1178.
48. (a) Kantlehner, W. Eur. J. Org. Chem., 2003, 2530 and reference cited therein; (b) Bagno, A.;
Kantlehner, W.; Kress, R.; Saielli, G.; Stoyanov, E. J. Org. Chem., 2006, 71, 9331.
49. (a) Horspool, W. M.; Pauson, P. L. J. Chem. Soc., 1965, 5162; (b) Ziegler, G.; Kantlehner, W. Z.
Naturforsch. B., 2001, 56, 1172.
50. Hansen, T. V.; Skattebl, L. Tetrahedron Lett., 2005, 46, 3357.
51. Odlo, K.; Klaveness, J.; Rongved, P.; Hansen, T. V. Tetrahedron Lett., 2006, 47, 1101.
52. Hansen, T. V.; Skattebl, L. Tetrahedron Lett., 2005, 46, 3829.
53. Anwar, H. F. Submitted as a spotlight article to Synlett.
54. Olsen, R. S.; Fataftah, Z. A.; Rathke, M. W. Synth. Commun., 1986, 16, 1133.
55. (a) Rathke, M. W.; Cowan, P. J. J. Org. Chem., 1985, 50, 2622; (b) Rathke, M. W.; Nowak, M. A.
Synth. Commun., 1985, 15, 1039.
56. Clay, R. J.; Collom, T. A.; Karrick, G. L.; Wemple J. Synthesis, 1993, 290.
18
57. (a) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc., 2002, 124, 392; (b)
Evans, D. A.; Downey, C. W.; Shaw, J. T.; Tedrow, J. S. Org. Lett., 2002, 4, 1127.
58. Hayashi, K.; Kujime, E.; Katayama, H.; Sano, S.; Nagao, Y. Chem. Pharm. Bull., 2007, 55, 1773.
59. Messer, R.; Fuhrer C. A.; Haner, R. Curr. Opin. Chem. Biol., 2005, 9, 259.
19
2. RESULTS AND DISCUSSION
2.1 Application of the ortho-Formylation Method
2.1.1 Synthesis of ortho-Hydroxycinnamate Esters
The aim of this study was to develop a simple and efficient procedure for the synthesis of
cinnamic esters. Cinnamic esters and their derivatives are useful intermediates for the
synthesis of heterocyclic compounds
1
and they are also used as antioxidants.
2
One of the
most common procedures for the preparation of cinnamic esters is the Perkin reaction. In
this reaction, the respective aldehyde reacts with acetic anhydride and anhydrous sodium- or
potassium acetate, yielding an ,-unsaturated acid. Esterification with an alcohol affords
the corresponding cinnamate ester (Scheme 2.1).
3
However, the Perkin reaction is often
hampered by low yields,
4
especially for the preparation of ortho-hydroxycinnamate esters
from salicylaldehydes.
5
,-Unsaturated esters are readily available using the Wittig reaction between an aldehyde
and an ylide (Scheme 2.2).
6
20
The ortho-formylation of phenols (as mentioned in the introduction) to salicylaldehydes
was described by Skattebl et al.
7a,b
by heating a mixture of the phenol, anhydrous MgCl
2
,
triethylamine, and paraformaldehyde in refluxing THF. Different alkyl- and halogen-
substituted phenols afford excellent yields of the corresponding salicylaldehydes.
Since phenols are inexpensive and readily available, we wanted to use the Casnati-
Skattebl
7
ortho-formylation method to prepare ortho-hydroxycinnamate esters. Hansen
and Skattebl tried the Perkin reaction by a one-pot procedure but this protocol failed.
8
However, the Wittig reaction was successful. After the phenols were converted to
salicylaldehydes, a solution of methyl (triphenylphosphoranylidene)acetate in
dichloromethane was added dropwise. After stirring 48 hours at ambient temperature
conversion was completed (Scheme 2.3).
This reaction was carried out with both 2- and 4-halogen-substituted phenols as starting
materials and the corresponding cinnamates were obtained in 60-78% yields (Table 2.1).
Moreover, this one-pot process, with two or more transformations, offers a number of
advantages. In particular, the direct transformation of intermediates to the desired products
reduces the time normally spent on isolation and purification.
New compounds were characterized on the basis of spectral data. The (E)-configuration
which is normally observed for this type of Wittig reactions was established by
1
H NMR
spectroscopy displaying trans-coupling constants in the range J = 15.8-16.2 Hz (Paper I).
21
Table 2.1. One-pot synthesis of ortho-hydroxycinnamate esters.
In the case of alkyl (R = Me, t-Bu) and phenoxy-substituted phenols, the reactions did not
go to completion even after stirring at room temperature for 21 hours. However, after
heating for 210 hours at gentle reflux, complete conversion was observed. The methyl
ortho-hydroxycinnamates 68, 69, and 70 were accompanied by minor amounts of the
Phenol Product Overall
yield %
74
73
61
63
78
66
65
60
Compounds 60 and 66 are known; for references
see the Appendix.
22
corresponding coumarins 71, 72, and 73, respectively (Table 2.2). We anticipate that the
ortho-hydroxycinnamate esters, upon heating isomerize to the (Z)-isomers which cyclize to
the coumarins.
Table 2.2 One-pot synthesis of ortho-hydroxycinnamate esters.
2.1.2 Synthesis of Substituted Salicylamines
Salicylamines and their derivatives are useful intermediates for the synthesis of heterocyclic
compounds, such as benzoxazines,
9
benz[1,2,3]oxathiazine 2-oxides,
10
and benz[1,3]oxazin-
2-ones.
11
Some salicylamines were tested as potential metal complexing agents including
metal ions extractants.
12
They were also tested as catalyst components in organic
synthesis.
13
Some salicylamines possess antimalarial and antimicrobial activity.
14
Aminomethylation of phenols is traditionally achieved with formaldehyde and amines under
acidic conditions using the Mannich reaction,
15,16
which occurs readily in ortho- and para-
positions affording polysubstituted phenols.
17
The position and nature of the substituents as
well as the reaction conditions play an important role on the orientation of the Mannich
reaction (Scheme 2.4).
18
Phenol Product (Overall yield %)
Compounds 68, 69, and 71 are known; for references
see the Appendix.
23
OH
N
R
3
R
2
OH
N
R
3
R
2
N
R
3
R
2
OH
N
R
3
R
2
OH
N
R
3
R
2
R
4
OH
R
4
CH
2
O, NHR
2
R
3
R
1
R
1
OH
CH
2
O, NHR
2
R
3
R
2
= R
3
= Me or Et
Scheme 2.4 Synthesis oI substituted salicylamines employing the Mannich reaction
1 74 75
76
77 78
R
1
R
1
R
1 R
1
When 2-chlorophenol (1c) was treated with 37% aqueous formaldehyde and 2-bromoaniline
at room temperature, <10% yield of the Mannich product was obtained together with
polymeric material.
19
Pochini et al. reported that phenols 1a-d reacted with Eschenmosers salt (N,N-
dimethylmethylene iminium iodide) in the presence of potassium carbonate affording
exclusively ortho-substituted products 79-82 in yields ranging from 75-98% (Scheme 2.5).
20
Recently, Ley and co-workers reported one example of a carbonate exchange resin
catalyzed reaction between 2-allylphenol (1h) and Eschenmosers salt giving 2-allyl-6-
((dimethylamino)-methyl)phenol (84) in excellent yield. This method avoids distillation or
recrystallization (Scheme 2.6).
21
24
Eschenmosers salt is commercially available, but can be prepared from N,N,N',N'-
tetramethylmethylenediamine with CH
2
ClI or CH
2
I
2
in DMSO at ambient temperature.
22
We decided to use the combination of MgCl
2
-Et
3
N as the base system in the Mannich
reaction. Eschenmosers salt was added to a mixture of MgCl
2
-Et
3
N and 2-methylphenol
(1b) in dichloromethane. After stirring for 3 hours at ambient temperature, complete
conversion of the phenol was observed, and only one regioisomer of the Mannich base 80
was isolated in 82% yield (Scheme 2.7 and Table 2.3). Several other 2-substituted phenols
were subjected to the same conditions and the corresponding Mannich bases 81-88 were
obtained in 66-83% yields. An almost quantitative yield of the product 90 was obtained
when -naphthol (89) was subjected to these reaction conditions. According to the
1
H NMR
spectra of the crude reaction mixtures, complete regioselectivity was observed in all cases.
The products were identified by physical and spectral data (Paper II).
Mannich bases are versatile intermediates for the synthesis of a wide range of biologically
active compounds, and our protocol compares favorably with others when considering
yields, regioselectivity, and simplicity.
23
25
Table 2.3 Synthesis of substituted N,N-dimethylsalicylamines by Mannich reaction
Then we tried another iminium salt
24
under the same reaction conditions, but this was
unsuccessful. Since few other methods for the synthesis of salicylamines have been
reported,
25
facile and efficient procedures for the synthesis of mono N-substituted
salicylamines are still desirable. We turned our attention to the synthesis of N-substituted
salicylamines by a simple and regioselective method (Scheme 2.8).
26
Phenol Product Overall
yield %
Time (h)
/solvent
82
5/toluene
77
3/CH2Cl2
82
8/CH2Cl2
83
3/CH2Cl2
79
2/CH2Cl2
66
12/CH2Cl2
98
0.5/CH2Cl2
Compounds 80, 81, and 90 are known; for references see the
Appendix.
26
As previously described, the salicylaldehydes were prepared from phenols 1 and 4 by our
ortho-formylation method.
7a
A solution of an amine followed by addition of NaBH
4
was
then added in a one-pot procedure. After heating to reflux for 30 minutes and further stirring
the reaction mixture for another 210 hours at room temperature, the reaction mixture was
worked up in the usual manner. When necessary, the products 97-112 were purified by
column chromatography and characterized by physical and spectral data. This one-pot
procedure combining formylation and reductive amination was carried out with both alkyl
and halogen substituted phenols as starting materials, and the overall yields ranged from 51-
74% (Scheme 2.8 and Table 2.4).
Table 2.4 Syntheses of mono N-substituted salicylamines
Phenol Amine Product
Overall
yield %
NH
2
Br
91
51
OH
Br
1f
56
57
58
27
68
61
55
NH
2
OEt
94
56
61
51
64
63
NH
2
Br
91
74
28
73
66
69
Compounds 109 and 111 are known; for references see the Appendix.
2.1.3 One-pot Synthesis of Substituted Dihydro-2H-1,3-benzoxazines
The aforementioned protocol for the preparation of dihydro-2H-1,3-benzoxazines was
investigated further. The solution of mono N-substituted benzylamine was treated with two
equivalents of paraformaldehyde which gave, after purification, substituted dihydro-2H-1,3-
benzoxazines 113-116 in 38-53% isolated yields in a one-pot sequence (Scheme 2.9).
Benzoxazines have previously been reported to exhibit a wide range of interesting
biological activities.
27
The operational simplicity of this method makes it attractive for
preparative use as well as for the synthesis of screening libraries for drug discovery.
29
2.1.4 Synthesis of Substituted Salicylnitriles
The aim of this study was to convert phenols to substituted salicylnitriles by a mild and
reliable method.
Aromatic nitriles can be prepared by the Rosenmund-von Braun reaction
28,29
using metal-
mediated displacement of aromatic halides by cyanide ion (Scheme 2.10). These
compounds are versatile starting materials for amides, amines, esters, carboxylic acids, etc.,
as well as for the synthesis of heterocyclic and biologically active compounds.
30
The
disadvantage of this method is the use of toxic cyanide salts and high temperatures (>150-
160 C), which are not suitable for industrial applications. Hence, it is not surprising that
only few examples of the preparation of substituted salicylnitriles have been reported using
the Rosenmund-von Braun reaction.
31
There are few other methods to convert phenol (1a) to salicylnitrile (117, 2-
hydroxybenzonitrile) (Scheme 2.11);
32
however, several methods are known for the
transformation of salicylaldehyde to salicylnitrile via dehydration of aldoximes
33
or by
using reagents such as sodium bis(trimethylsilyl)amide,
34
aqueous ammonia/sodium
dichloroiodate,
35
and 1,1-dimethylhydrazine/dimethyl sulphate in the presence of K
2
CO
3
.
36
Recently, hypervalent iodine reagents such as 2-iodoxybenzoic acid (IBX) and Dess-Martin
periodinane (DMP) have attracted interest as oxidation agents.
37
These reagents are
commercially available or can be prepared from 2-iodobenzoic acid (Scheme 2.12).
38
30
The oxidation of imines to nitriles using IBX in aqueous ammonia was recently reported by
Akamanchi and co-workers (Scheme 2.13).
39
O
O
OH
R-CHO RCH=NH R-CN
Scheme 2.13
BX
NH
3
We decided to adapt this method for the synthesis of substituted salicylnitriles from
phenols. A complete regioselective introduction of the nitrile group, via oxidation of imine
intermediates from salicylaldehydes, was expected to give the desired salicylnitriles.
Furthermore, few substituted salicylnitriles are commercially available.
Salicylaldehydes were formed by the ortho-formylation of the corresponding phenols as
previously discussed, and subsequent treatment with aqueous ammonia afforded the
corresponding salicylimines. The imines were then oxidized with 1.2 equivalents of IBX
(SIBX) to salicylnitriles in a one-pot operation (Scheme 2.14).
2-Alkyl and 2-halogen substituted phenols 1b-f, h were subjected to this protocol, affording
the corresponding salicylnitriles 119-124 in 48-71% isolated yields over three steps. As
expected, the reaction of 4-substituted phenols 4c, h, j, l furnished the 5-substituted
31
salicylnitriles 125-128 in comparable yields. Similarly, 2,4-di-substituted phenol 44a gave
129 in 56% yield. (Table 2.5).
Table 2.5. One-pot synthesis of substituted salicylnitriles.
Compound 124 was useful for the synthesis of a benzofuran derivative as described by
Sekizaki et al.
40
Moreover, 2,3-(methylenedioxy)-phenol (118) was converted in 58% yield
to the corresponding salicylnitrile 130, which may be of interest as a starting material for
Phenol Product
Overall
yield %
Phenol Product
Overall
yield %
62
67
70
67
OH
W-Bu
1d
OH
W-Bu CN
121
71
54
48
70
55
56
53
58
Compounds 119, 120, 123, 124, 128, and 129 are known; for references see the Appendix.
32
the syntheses of some highly oxygenated natural products such as powelline, narciclasine
and pancratistatin (Figure 2.1).
41,42
As expected complete regioselectivity was observed in all cases. All products were
identified and characterized by physical and spectral data.
Starting from 2-chlorophenol (1c) we also tried to use DMP as the oxidant but the yield was
lower than with IBX under same reaction conditions (Scheme 2.15).
These results have been summarized in Paper I, II, and III.
33
2.2 Applications of the ortho-Formylation Method in Natural Product Synthesis
2.2.1 First Total Synthesis of ()-Powelline
The aim of this study was to achieve an efficient total synthesis of ()-powelline 132, a
natural product not previously synthesized.
The 2,3,4,4a-tetrahydro-1H,6H-5,10b-ethanophenanthridine (cis-3a-aryloctahydroindole
nucleus) skeleton characterizes the crinine sub-class of Amaryllidaceae alkaloids such as
crinine (131), powelline (132), crinamidine (133), and undulatine (134) (Figure 2.2).
43
(+)-Powelline 132 has been isolated from several Amaryllidaceae species like Crinum
bulbispermum
44
and Crinum moorei.
45
Several members in this class of alkaloids display interesting biological properties such as
acetylcholinesterase inhibition,
46
cytotoxicity,
47
and antimalarial
48
effects. Due to their
interesting structures, limited supply, and their bioactivities, these natural products
constitute obvious targets for total synthesis.
49
Our strategy was dependent on an intramolecular phenolic coupling reaction and an
intramolecular Michael addition as key steps (Figure 2.3).
34
We started our synthesis of this alkaloid with ortho-formylation of 2,3-
methylenedioxyphenol (118). The salicylaldehyde was, without isolation, treated with
tyramine (137) and NaBH
4
in a one-pot reaction as previously described
50
to yield the
secondary amine 138. Monoprotection of the amine group with TFA-anhydride and DMAP
as a base afforded 139. The attempted intramolecular phenolic coupling of 139 using the
hypervalent iodine reagent [bis(trifluoroacetoxy)iodo]-benzene (PIFA) in trifluoroethanol
failed to give compound 140. However, compound 141 has previously successfully
synthesized by Kodama et al. in 74% yield under the same reaction conditions.
51
Hence, we
decided to protect the methylenedioxyphenol hydroxyl group before performing the
intramolecular phenolic coupling reaction (Scheme 2.16).
35
Our new approach started with the preparation of salicylaldehyde 142 in 96% yield.
Protection of the hydroxyl group with MeI and K
2
CO
3
afforded 143 in 96% yield, followed
by reductive amination with tyramine (137) to the amine 136 in 82% yield (Scheme 2.17).
Although we no longer have our one-pot procedure we prepared 2-methoxy-3,4-
methylenedioxybenzaldehyde (143, croweacin aldehyde), which has been used as a key
intermediate for the syntheses of a variety of natural products (Figure 2.4).
52
It was first
obtained as an oxidative degradation product of 1-allyl-2-methoxy-3,4-
methylenedioxybenzene (144, croweacin), which occurs in the essential oil separated from
the leaves and terminal branchlets of Eriostemon crowei. At the same time, 143 was
synthesized from 7,8-dihydroxycoumarin (146, daphnetin).
53
Since then, croweacin
aldehyde (143) has been obtained by several routes. Apparently, the Vilsmeier formylation
of 148 is the best method reported in the literature, although the product was contaminated
by its regioisomer 149 (10-35%) (Scheme 2.18).
52c,54
We have developed a mild and reliable
method to synthesize 143 with excellent yield (92%) over two steps from 118, and with
complete regioselectivity using the Casnati-Skattebl ortho-formylation method.
7
36
Scheme 2.18
O
O
OMe
CHO
O
O
OMe
O
O
OMe
Me
OH
OH
O
O
HO
HO
OMe
O
O
COOH
144 Croweacin
146 Daphnetin
NaOH, Me
2
SO
4
O
3
[O]
KMnO
4
/Me
2
CO
Pb(OAc)
4
/AcOH
O
O
OMe
CHO
O
O
OMe
DMF/POCl
3
or PhN(Me)CHO/
POCl
3
+
145 143
147
143
148
149
(12-54%)
(10-35%)
The next step was monoprotection of the amine function in 136 with TFA-anhydride using
DMAP as a base in dichloromethane to afford 150. Reaction of the protected amine with the
hypervalent iodine reagent [bis(trifluoroacetoxy)iodo]-benzene (PIFA) in trifluoroethanol
gave compound 151 in 46% yield over the two steps (Scheme 2.19).
37
The intramolecular Michael cyclization reaction of compound 151 was achieved with
aqueous potassium hydroxide affording racemic oxopowelline 152. Subsequent Luche
reduction
55,56
using NaBH
4
and CeCl
3
gave alcohol 153 in 60% yield over the two steps
(Scheme 2.20). A NOE effect was observed between protons H-4a (3.02 ppm) and H-3
(4.16 ppm), confirming the relative stereochemistry depicted for compound 153 (Figure 2.5
and 2.6).
38
Figure 2.6. NOESY experiment of compound 153. The spectrum was recorded on a Bruker
Avance DPX- 600 MHz
Finally, Mitsunobu inversion
57
of the C-3 hydroxyl group yielded racemic powelline 132 in
50% yield with spectral data in accord with those previously reported
58,44
(Scheme 2.21).
39
Next, we tried reducing oxopowelline 152 to powelline 132 by an asymmetric reduction of
the carbonyl group. However, using both CBS catalysts ((R)-2-methyl-CBS-
oxazaborolidine and (S)-2-methyl-CBS-oxazaborolidine) and 2-(3-nitrophenyl)-1,3,2-
dioxaborolane-4S,5S-dicarboxylic acid failed to give the correct configuration of powelline,
instead complex diastereomeric mixtures of epipowelline and powelline were obtained.
Future work in our group includes total syntheses of crinamidine (133), undulatine (134),
and buphanidrine (154) from the common intermediate 152, as well as developing
asymmetric syntheses of the alkaloids 132, 133, 134, and 154 (Figure 2.7).
These results have been summarized in Paper IV and the experimental procedures, physical
data, and spectroscopic data have been presented in the Appendix.
40
2.2.2 First Total Synthesis of a Polyunsaturated Chromone
The aim of this study was to develop an efficient total synthesis of all-(Z)-5,7-dihydroxy-2-
(4,7,10,13,16-nonadecapentaenyl)chromone (155). To the best of our knowledge, no total
synthesis has previously been reported for this natural product (Figure 2.8).
Marine organisms have proven to be a rich source of biologically interesting secondary
metabolites.
59,60
The isolation and structural elucidation of dihydroxychromone 155 from
the pacific brown algae Zonaria tournefortii was reported in 1982 by Plattelli and Tringali
61
Later, this natural product was also isolated from two other Zonaria species.
62
Compound 155 contains the same number of methylene interrupted cis double bonds as
those present in eicosapentaenoic acid (156, EPA), which is a polyunsaturated fatty acid of
the -3 family found in fish oil (Figure 2.9).
Our retrosynthetic analysis lead to EPA and a protected phloroglucinol aldehyde as starting
materials (Figure 2.10).
A substantial amount of pharmacological and clinical data accumulated in the last 15-20
years indicates a wide spectrum of biological effects of EPA;
63
the chromone 155 may be
regarded as an analogue. Hence, it would be of interest to develop a total synthesis of 155 to
obtain sufficient material for biological testing.
41
Our synthesis of 155 started with the preparation of aldehyde 162 in 97% yield as
previously described.
64
The aldehyde was transformed to the terminal alkyne 159 by either a
Colvin rearrangement
65
(58% yield) or by the Corey-Fuchs reaction
66
(52% yield) (Scheme
2.22).
42
CO
2
Et CHO
161 162
159
DBAL-H,
toluene, -78
o
C
LDA, TMSCHN
2
,THF,
-78
o
C, (58%)
(97%)
Scheme 2.22
Br
Br
CBr
4
, PPh
3
,
Zn,CH
2
Cl
2
, r.t.
(82%)
MeLi, ether,
-78
o
C (63%)
163
The reaction of the lithium carbanion of 159 at -78
o
C with a THF solution of 2,4,6-
trimethoxybenzaldehyde (164) yielded the acetylene 165. Oxidation of 165 with MnO
2
afforded ketone 166 (Scheme 2.23).
OMe
OH
MeO
OMe
OMe
O
MeO
OMe
OMe
O
MeO
OMe
159 164
Q-BuLi (1.1 equiv)
THF, -78
o
C - r.t.
MnO
2
,
CH
2
Cl
2
, r.t.
+
165
(96%)
(58%)
166
Scheme 2.23
We expected that deprotection of 166, followed by an intramolecular Michael addition,
would yield the natural product 155. However, decomposition of the starting material was
43
observed with most common deprotection methods, such as AlCl
3
/CH
3
CN, BBr
3
/CH
2
Cl
2
,
and MeSNa/DMF.
67
Then, we decided to perform some model studies. Reaction of MOM-protected
salicylaldehyde 167 with the carbanion of 159 at -78
o
C gave the secondary alcohol 168 in
53% yield. Oxidization with MnO
2
produced the ketone 169 in 94% yield. Mild
deprotection of 169 with HCl in EtOH at ambient temperature afforded 170 in 67% yield.
An intramolecular Michael addition under mild basic conditions (K
2
CO
3
, acetone), afforded
the didehydroxy natural product 171 in 66% yield (Scheme 2.24).
We then prepared the known 2,4,6-tris(methoxymethoxy)benzaldehyde 172 according to a
literature procedure.
68
Addition of the aldehyde 172 in THF to the carbanion of 159 at -78
o
C yielded the secondary alcohol 173 in 60% yield. Oxidiation of 173 with MnO
2
yielded
the MOM-protected ketone 174 in 88% yield (Scheme 2.25).
44
OMOM
OH
MOMO
MOMO
OMOM
O
MOMO
MOMO
OMOM
O
MOMO
MOMO
159 172
Q-BuLi (1.1 equiv)
THF, -78
o
C - r.t.
MnO
2
,
CH
2
Cl
2
, r.t.
+
173
(88%)
(58%)
174
Scheme 2.25
Mild deprotection of 174 with HCl in EtOH at ambient temperature, followed by the
intramolecular Michael addition under basic conditions (K
2
CO
3
, acetone), afforded the
natural product 155 in 49% yield for the last two steps (Scheme 2.26). All spectral data (
1
H,
13
C, Dept-NMR, IR, MS, HRMS, and LC-MS) were in agreement with those previously
reported for the natural product.
61,62
These results have been described in Paper V and the experimental procedures, physical
data, and spectroscopic data have been compiled in the Appendix.
45
We are currently working on the synthesis of derivatives of this natural product, including
one with a saturated alkyl chain. Polyunsaturated fatty acids and their derivatives are
expected to show strong binding to peroxisome proliferator-activated receptors (PPARs).
Hence, these types of derivatives may be used as a basis for the development of drugs against
diabetes and metabolic syndrome.
69
The results from biological testing will be reported in due
course (Figure 2.11).
46
3. SUMMARY
We have reported the transformation of phenols into ortho-hydroxycinnamates,
salicylamines, benzoxazines, and salicylnitriles in good overall yields by simple,
regioselective, and one-pot procedures using the advantage of the ortho-formylation
method. Moreover, these one-pot processes offer the advantage of both economic and
environmentally benign methods. We also used the MgCl
2
-Et
3
N base system in the
Mannich reaction with complete regioselectity.
We have described the first total synthesis of ()-powelline in 10% overall yield over eight
steps.
We have reported the first total synthesis of the naturally occurring all-(Z)-5,7-dihydroxy-2-
(4,7,10,13,16-nonadecapentaenyl)chromone in six steps from the ethyl ester of
eicosapentaenoic acid with an overall of 14% yield.
47
References and Notes
1. (a) Joule, J. A.; Mills, K. Heterocyclic Chemistry, 4th ed.; Blackwell Publishing: Oxford, 2000; pp
170189; (b) Ringk, W. F. In Kirk Othmer Encyclopedia of Chemical Technology, 3rd ed.; John
Wiley and Sons: New York, 1981; Vol. 6, pp 143149; (c) Adams, R.; Bockstahler, T. E. J. Am.
Chem. Soc., 1952, 74, 5346.
2. (a) Ohkatsu, Y.; Aoshima, T.; Yamaguchi, K. Nippon Kagaku Kaishi, 1998, 711; (b) Takahashi, M.
Jpn. Kokai Tokkyo Koho, JP 2006219402, 2006.
3. (a) Perkin, W. H. J. Chem. Soc., 1868, 21, 53; (b) Johnson, J. R. In The Perkin Reaction and
Related Reactions in Organic Reactions; Adams, R., Ed.; John Wiley and Sons: New York, 1942;
Vol. 1, pp 218231.
4. (a) Koepp, E.; Vgtle, F. Synthesis, 1987, 177; (b) Aslam, M.; Stansbury, W. F.; Reiter, R. J.;
Larkin, D. R. J. Org. Chem., 1997, 62, 1550.
5. (a) Adams, R.; Mathieu, J. J. Am. Chem. Soc., 1948, 70, 2120; (b) Adams, R.; Bockstahler, T. E. J.
Am. Chem. Soc., 1952, 74, 5346; (c) Chenault, J.; Dupin, J. F. E. Synth. Commun., 1984, 14, 1059;
(d) Dupin, J. F. E.; Chenault, J. Synth. Commun., 1985, 15, 581.
6. (a) El-Batta, A.; Jiang, C.; Zhao, W.; Anness, R.; Cooksy, A. L.; Bergdahl, M. J. Org. Chem., 2007,
72, 5244; (b) Mahajan, R. P.; Patil, S. L.; Mali, R. S. Org. Prep. Proced. Int., 2005, 37, 286.
7. (a) Hansen, T. V.; Skattebl, L. Org. Synth., 2005, 82, 64; (b) Hofslkken, N. U.; Skattebl, L. Acta
Chem. Scand., 1999, 53, 258; (c) Casiraghi, G.; Casnati, G.; Cornia, M.; Pochini, A.; Puglia, G.;
Sartori, G.; Ungaro, R. J. Chem. Soc., Perkin Trans 1, 1978, 318; (d) Casnati, G.; Crisafulli, M.;
Ricca, A. Tetrahedron Lett., 1965, 6, 243.
8. Hansen, T. V.; Skattebl, L. unpublished results.
9. Joglekar, S. J.; Samant, S. D. J. Indian Chem. Soc., 1988, 65, 110.
10. Cazaux, L.; Tisnes, P. J. Heterocyclic Chem., 1976, 13, 665.
11. Mindl, J.; Hrabik, O.; Sterba, V.; Kavalek, J. Collect. Czech. Chem. Commun., 2000, 65, 1262.
12. Beretka, J.; West, B. O.; O'Connor, M. J. Aust. J. Chem., 1964, 17, 192; (b) Butvin, P.; Lubkeova,
S.; Capalova, K.; Pikulikova, Z. Chem. Pap., 1994, 48, 15.
13. Bujnowski, K.; Adamczyk, A.; Synoradzki, L. Org. Prep. Proced. Int., 2007, 39, 153 and
references cited therein.
14. (a) Burckhalter, J. H.; Tendick, F. H.; Jones, E. M.; Jones, P. A.; Holcomb, W. F.; Rawlins, A. L.
J. Am. Chem. Soc., 1948, 70, 1363; (b) Molodykh, Z. V.; Kudryavtseva, L. A.; Shagidullina, R. A.;
Shtanova, L. V.; Teitel'baum, A. B.; Zotova, A. M.; Ryzhkina, I. S.; Kudrina, M. A.; Anisimova,
N. N.; Ivanov, B. E. Khim.-Farm. Zh., 1987, 21, 182; (c) Iraidova, I. S.; Molodykh, Z. V.;
Kudryavtseva, L. A.; Zotova, A. M.; Ryzhkina, I. S.; Shagidullina, R. A.; Ivanov, B. E. Fiziol. Akt.
Veshchestva, 1987, 19, 30; (d) Jensen, N. P.; Chang, M. N. Eur. Pat. Appl. EP 82-111258, 1983; (e)
Pandeya, S. N.; Lakshmi,V. S.; Pandey, A. Ind. J. Pharm. Sci., 2003, 65, 213.
15. Mannich, C. Arch. Pharm., 1917, 255, 261.
16. (a) Tramontini, M. Synthesis, 1973, 703; (b) Tramontini, M.; Luigi, A. Tetrahedron, 1990, 46,
1791; (c) Arend, M.; Westermann, B.; Risch, N. Angew. Chem.-Int. Edit., 1998, 37, 1045; (d)
Kobayashi, S.; Ueno, M. Comprehensive Asymmetric Catalysis: Supplement 1; Springer: Berlin,
2004; pp 143150.
17. Baekeland, L. H. J. Ind. Eng. Chem., 1909, 1, 149.
18. (a) Tychopoulos, V.; Tyman, J. H. P Synth. Commun., 1986, 16, 1401; (b) Hon, Y.-S.; Chou, Y.-
Y.; Wu, I.-C. Synth. Commun., 2004, 34, 2253.
19. Baekeland, L. H. J. Ind. Eng. Chem., 1909, 1, 149.
20. Pochini, A.; Puglia, G.; Ungaro, R. Synthesis, 1983, 906.
48
21. Bream, R. N.; Ley, S. V.; Procopiou, P. A. Org. Lett., 2002, 4, 3793.
22. (a) Clark, G. R.; Shaw, G. L.; Surman, P. W. J.; Taylor, M. J.; Steele, D. J. Chem. Soc., Faraday
Trans., 1994, 90, 3139; (b) Miyano, S.; Hokari, H.; Hashimoto, H. Bull. Chem. Soc. Jpn., 1982, 55,
534.
23. (a) Boehme, H.; Haake, M. Adv.Org. Chem., 1976, 9, 107; (b) Heaney, H.; Papageorgiou, G.;
Wilkins, R. F. Tetrahedron, 1997, 53, 13361; (c) Caulfield, M. J.; Russo, T.; Solomon, D. H. Aust.
J. Chem., 2000, 53, 545.
24. N-Ethyl-N-methyleneethanaminium iodide was synthesized from N,N,N',N'-tetraethylmethane-
diamine and CH
2
ClI.
22a
25. Mathieu, J.; Weill-Raynal, J. Formation of CC Bonds; George Thieme: Stuttgart, 1973; Vol. 1, pp
95103.
26. Green, R. W.; Sleet, R. J. Aust. J. Chem., 1969, 22, 917.
27. Sicker, D.; Schulz, M. Stud. Nat. Prod. Chem., 2002, 27, 185.
28. (a) Pongratz, A. Monatsh. Chem., 1927, 48, 585; (b) Pongratz, A.; Pochmuler, E. Monatsh. Chem.,
1929, 51, 228.
29. (a) von Braun, J.; Manz, G. Liebigs Ann. Chem., 1931, 488, 111; (b) Rosenmund, K. W.; Struck,
E. Chem. Ber., 1919, 52B, 1749.
30. (a) Herr, R. J. Bioorg. Med. Chem., 2002, 10, 3379; (b) Schmidt, A. In Science of Synthesis;
Murahashi, S.-I., Ed.; Georg Thieme, 2004; Vol. 19, pp 133161; (c) Larock, R. Comprehensive
Organic Transformations. A Guide to Functional Group Preparations; VCH: New York, 1989.
31. (a) Ellis, G. P.; Hudson, H. V. J. Chem. Res. (S), 1985, 372; (b) Jones, T. H.; Blum, M. S.; Fales,
H. M. Synth. Commun., 1981, 11, 889; (c) Adachi, M.; Sugasawa, T. Synth. Commun., 1990, 20,
71.
32. (a) Bigi, F.; Maggi, R.; Sartori, G.; Casnati, G.; Bocelli, G. Gazz. Chim. Ital., 1992, 122, 283; (b)
Adachi, M.; Sugasawa, T. Synth. Commun., 1990, 20, 71; (c) So, Y.-H.; Miller, L. L. J. Am. Chem.
Soc., 1980, 102, 7119.
33. (a) Zhu, Q.; Fan, A.; Wang, Y.; Zhu, X.; Wang, Z.; Wu, M.; Zheng, Y. Appl. Environ. Microbiol.,
2007, 73, 6053; (b) Dewan, S. K.; Singh, R.; Kumar, A. ARKIVOC, 2006, (ii), 41; (c) Niknam, K.;
Karami, B.; Kiasat, A. R. Bull. Korean Chem. Soc., 2005, 26, 975; (d) Dewan, S. K.; Singh, R.;
Kumar, A. Synth. Commun., 2004, 34, 2025; (e) Sharghi, H.; Sarvari, M. H. Synthesis, 2003, 243;
(f) Sharghi, H.; Sarvari, M. H. Tetrahedron, 2002, 58, 10323; (g) Ali, S. I.; Nikalje, M. D.;
Dewkar, G. K.; Paraskar, A. S.; Jagtap, H. S.; Sudalai, A. J. Chem. Res. (S), 2000, 30; (h)
Chakraborti, A. K.; Kaur, G. Tetrahedron, 1999, 55, 13265.
34. Hwu, J. R.; Wong, F. F. Eur. J. Org. Chem., 2006, 2513.
35. Telvekar, V. N.; Patel, K. N.; Kundaikar, H. S.; Chaudhari, H. K. Tetrahedron Lett., 2008, 49,
2213.
36. Kamal, A.; Arifuddin, M.; Rao, N. V. Synth. Commun., 1998, 28, 4507.
37. (a) Frigerio, M.; Santagostino, M. Tetrahedron Lett., 1994, 35, 8019; (b) Dess, D. B.; Martin, J. C.
J. Am. Chem. Soc., 1991, 113, 7277; (c) Chaudhari, S. S. Synlett, 2000, 278; (d) Nicolaou, K. C.;
Mathison, C. J. N.; Montagnon, T. J. Am. Chem. Soc., 2004, 126, 5192; (e) Nicolaou, K. C.; Baran,
P. S.; Zhong, Y.- L. J. Am. Chem. Soc., 2001, 123, 3183; (f) Zhdankin, V. V.; Stang, P. J. Chem.
Rev., 2002, 102, 2523; (g) Zhdankin, V. V.; Stang, P. J. Chem. Rev., 2008, 108, 5299.
38. (a) Boeckman, R. K.; Shao, P.; Mullins, J. J. Org. Synth. Coll., 2004, 10, 696; Org. Synth., 2000,
77, 141; (b) Ireland, R. E.; Liu, L. J. Org. Chem., 1993, 58, 2899; (c) Frigerio, M.; Santagostino,
M.; Sputore, S. J. Org. Chem., 1999, 64, 4537.
39. Arote, N. D.; Bhalearo, D. S.; Akamanchi, K. G. Tetrahedron Lett., 2007, 48, 3651.
40. Sekizaki, H.; Itoh, K.; Toyota, E.; Tanizawa, K. Heterocycles, 2003, 59, 237.
49
41. (a) Chapleur, Y.; Chretien, F.; Ahmed, S. I.; Khaldi, M. Curr. Org. Synth., 2006, 3, 341; (b)
Rinner, U.; Hudlicky, T. Synlett, 2005, 365; (c) Hudlicky, T. J. Heterocycl. Chem., 2000, 37, 535.
42. (a) Elango, S.; Yan, T.-H. J. Org. Chem., 2002, 67, 6954; (b) Rigby, J. H.; Maharoof, U. S. M.;
Mateo, M. E. J. Am. Chem. Soc., 2000, 122, 6624.
43. (a) Martin, S. F. The Amaryllidaceae alkaloids In Alkaloids; Brossi, A.; Ed.; Academic: New York,
NY, 1987; Vol. 30, 251; (b) Hoshin, O. The Amaryllidaceae alkaloids In Alkaloids; Cordell, G. A.;
Ed.; Academic: New York, NY, 1998; Vol. 51, 323; (c) Jin, Z. Nat. Prod. Rep. 2007, 24, 886; (d)
Jin, Z. Nat. Prod. Rep., 2005, 22, 111; (e) Jin, Z. Nat. Prod. Rep., 2003, 20, 606; (f) Jin, Z., Li, Z.,
Huang, R. Nat. Prod. Rep., 2002, 19, 454; (g) Nguyen, T. N. T.; Titorenkova, T. V.; St. Bankova, V.;
Handjieva, N. V.; Popov, S. S. Fitoterapia, 2002, 73, 183; (h) Unver, N. Phytochem. Rev., 2007, 6,
125; (i) Lewis, J. R. Nat. Prod. Rep., 1990, 7, 549.
44. Kobayashi, S.; Tokumoto, T.; Kihara, M.; Imakura, Y.; Shingu, T.; Taira, Z. Chem. Pharm. Bull.,
1984, 32, 3015.
45. Fennell, C. W.; Elgorashi E. E.; van Staden, J. J. Nat. Prod., 2003, 66, 1524.
46. Elgorashi, E. E.; Stafford, G. I.; van Staden, J. Planta Med., 2004, 70, 260.
47. (a) Likhitwitayawuid, K.; Angerhofer, C. K.; Chai, H.; Pezzuto, J. M.; Cordell, G. A.; Ruangrungsi,
N. J. Nat. Prod., 1993, 56, 1331; (b) Lin, L. Z.; Hu, S. F.; Chai, H. B.; Pengsuparp, T.; Pezzuto, J.
M.; Cordell, G. A.; Ruangrungsi, N. Phytochem., 1995, 40, 1295; (c) McNulty, J.; Nair, J. J.;
Codina, C.; Bastida, J.; Pandey, S.; Gerasimoff, J.; Griffin, C. Phytochem., 2007, 68, 1068.
48. (a) Hoet, S.; Opperdoes, F.; Brun, R.; Quetin-Leclercq, J. Nat. Prod. Rep., 2004, 21, 353; (b)
Sener, B.; Orhan, I.; Satayavivad, J. Phytother. Res., 2003, 17, 1220; (c) Schwikkard, S.; van
Heerden, F. R. Nat. Prod. Rep., 2002, 19, 675; (d) Citoglu, G.; Tanker, M.; Gumusel, B. Phytother.
Res., 1998, 12, 205; (e) Weniger, B.; Italiano, L.; Beck, J. P.; Bastida, J.; Bergonon, S.; Codina, C.;
Lobstein, A.; Anton, R. Planta Med., 1995, 61, 77.
49. Syntheses of racemic crinine and epicrinine: (a) Tam, N. T.; Cho, C.-G. Org. Lett., 2008, 10, 601;
(b) Bru, C.; Guillou, C. Tetrahedron, 2006, 62, 9043; (c) Kodama, S.; Takita, H.; Kajimoto, T.;
Nishide, K.; Node, M. Tetrahedron, 2004, 60, 4901; (d) Pearson, W. H.; Lovering, F. E. J. Org.
Chem., 1998, 63, 3607; (e) Pearson, W. H.; Lovering, F. E. Tetrahedron Lett., 1994, 35, 9173; (f)
Martin, S. F.; Campbell, C. L. J. Org. Chem., 1988, 53, 3184; (g) Martin, S. F.; Campbell, C. L.
Tetrahedron Lett., 1987, 28, 503; (h) Overman, L. E.; Mendelson, L. T. J. Am. Chem. Soc., 1981,
103, 5579; (i) Whitlock, H. W. Jr.; Smith, G. L. J. Am. Chem. Soc., 1967, 89, 3600; (j) Muxfeldt,
H.; Schneider, R. S.; Mooberry, J. B. J. Am. Chem. Soc., 1966, 88, 3670; Synthesis of (-)-crinine:
(k) Overman, L. E.; Sugai, S. Helv. Chim. Acta, 1985, 68, 745.
50. Anwar, H. F.; Skattebl, L.; Hansen, T. V. Tetrahedron, 2007, 63, 9997.
51. Kodama, S.; Takita, H.; Kajimoto, T.; Nishide, K.; Node, M. Tetrahedron, 2004, 60, 4901.
52. (a) Passannanti, S.; Paternostro, M. P.; Piozzi, F.; Savona, G. Chem. Ind., 1975, 791; (b) Cleaver,
L.; Nimgirawath, S.; Ritchie, E.; Taylor, W. C. Aust. J. Chem., 1976, 29, 2003; (c) Coppola, G. M.;
Schuster, H. F. J. Heterocycl. Chem., 1989, 26, 957; (d) Adesomoju, A. A.; Davis, W. A.;
Rajaraman, R.; Pelletier, J. C.; Cava, M. P. J. Org. Chem., 1984, 49, 3220; (e) Shirasaka, T.;
Takuma, Y.; Shimpuku, T.; Imaki, N. J. Org. Chem., 1990, 55, 3767; (f) Nimgirawath, S.; Podoy,
P. Aust. J. Chem., 2000, 53, 527.
53. Penfold, A. R.; Ramage, G. R.; Simonsen, J. L. J. Chem. Soc., 1938, 756.
54. (a) Lin, J. G.; Zhang, W. G.; Zhao, R.; Niu, Z. Y.; Bao, K.; Liu, D. L.; Wang, N. L.; Yao, X. S.
Chin. Chem. Lett., 2006, 17, 307; (b) Shirasaka, T.; Takuma, Y.; Imaki, N. Synth. Commun., 1990,
20, 1213; (c) Fleischhacker, W.; Richter, B.; Urban, E. Monatsh. Chem., 1989, 120, 765; (d)
McKittrick, B. A.; Stevenson, R. J. Chem. Soc., Perkin Trans. 1, 1984, 709; (e) Brownell, W. B.;
Weston, A. W. J. Am. Chem. Soc., 1951, 73, 4971.
50
55. Bru, C.; Guillou, C. Tetrahedron, 2006, 62, 9043.
56. Luche, J. L.; Rodriguez-Hahn, L.; Crabbe, P. J. Chem. Soc. Chem. Commun., 1978, 601.
57. (a) Mitsunobu, O.; Yamada, M.; Mukaiyama, T. Bull. Chem. Soc. Jpn., 1967, 40, 935; (b)
Mitsunobu, O.; Yamada, M. Bull. Chem. Soc. Jpn., 1967, 40, 2380; (c) Mitsunobu, O. Synthesis,
1981, 1; (d) Lawrence, S. PharmaChem., 2002, 1, 12.
58. Frahm, A. W.; Ali, A. A.; Ramadan, M. A. Magn. Reson. Chem., 1985, 23, 804.
59. Rinehart, K. L.; Tachibana, K. J. Nat. Prod., 1995, 58, 344.
60. Faulkner, D. J. Nat. Prod. Rep., 2002, 19, 1.
61. Tringali, C.; Piattelli, M. Tetrahedron Lett., 1982, 23, 1509.
62. (a) Blackman, A. J.; Rogers, G. I.; Volkman, J. K. J. Nat. Prod., 1988, 51, 158; (b) El Hattab, M.;
Piovetti, L.; Chitour, C. E. J. Soc. Alger. Chim., 2006, 16, 69.
63. (a) Harris, W. S. Am. J. Clin. Nutr., 2008, 87, 1997S; (b) Calder, P. C. Mol. Nutr. Food Res., 2008,
52, 885; (c) Simopoulos, A. P. Exp. Biol. Med., 2008, 233, 674.
64. Holmeide, A. K.; Skattebl, L.; Sydnes, M. J. Chem. Soc., Perkin Trans. 1, 2001, 1942.
65. Colvin, E. W.; Hamill, B. J. J. Chem. Soc., Chem. Commun., 1973, 151.
66. Corey, E. J.; Fuchs, P. L. Tetrahedron Lett., 1972, 13, 3769.
67. Wuts, P. G. M.; Greene, T. W. Greenes Protective Groups in Organic Synthesis, 4th ed.; John
Wiley & Sons: Hoboken, NJ, 2007; pp 370382.
68. Graybill, T. L.; Casillas, E. G.; Pal, K.; Townsend, C. A. J. Am. Chem. Soc., 1999, 121, 7729.
69. Gani, O. A. Cardiovasc. Diabetol., 2008, 7, 6.
4. APPENDIX
52
Experimental
General Information
All reagents and solvents were used as purchased without further purification. Melting points
are uncorrected. Analytical TLC was performed using silica gel 60 F
254
Aluminium sheets
(Merck). Flash column chromatography was performed on silica gel 60 (4060 m, Fluka).
NMR spectra were recorded on a Bruker Avance DPX-300 MHz spectrometer for
1
H NMR and
75 MHz for
13
C NMR. Coupling constants (J) are reported in Hertz, and chemical shifts are
reported in parts per million () relative to CDCl
3
(7.26 ppm for
1
H and 77.0 ppm for
13
C),
DMSO-d
6
(2.49 ppm for
1
H and 39.5 ppm for
13
C), and CD
3
OD (3.31 ppm for
1
H and 49.15
ppm for
13
C). Mass spectra were recorded at 70 eV with Fissions VG Pro spectrometer. High
resolution mass spectra were performed with a VG Prospec mass spectrometer and with a
Micromass Q-TOF-2
TM
. The LC/MS analyses were performed on an Agilent Technologies
1200 Series (Eclipse XDB-C18 5m 4.6150mm), coupled with an Agilent 6310 ion trap.
2-(Methoxymethoxy)benzaldehyde (167) was prepared according to a literature procedure.
1
6-((4`-Hydroxyphenethylamino)methyl)-2,3-(methylenedioxy)-phenol (138)
Anhydrous magnesium chloride (0.95 g, 10 mmol), triethylamine (1.01 g, 10 mmol), and
paraformaldehyde (0.45 g, 15 mmol) were added to a dry THF solution (30 mL) of phenol 118
(0.69 g, 5 mmol). The reaction mixture was heated to reflux under an argon atmosphere for 4.5
h and the reaction was monitored by TLC (hexane/EtOAc 4:1). After complete consumption of
the phenol, a solution of the amine 137 (0.70 g, 5.1 mmol) in MeOH (5 mL) was added
dropwise. The reaction mixture was heated to reflux for 30 min and further stirred at room
temperature for an additional 2 h while monitored by TLC (hexane/EtOAc 1:4). After complete
consumption of the salicylaldehyde, a solution of NaBH
4
(0.38 g, 10 mmol) in MeOH (10 mL)
1. Harvey, R. G.; Cortez, C.; Ananthanarayan, T. P.; Schmolka, S. J. Org. Chem., 1988, 53, 3936.
53
was added dropwise over 15 min. The reaction mixture was stirred at ambient temperature for
10 h and the reaction monitored by TLC (hexane/EtOAc 1:4). After complete reduction of the
imine, the pH was adjusted to 5 by addition of HCl (1 N) and the reaction mixture extracted
with CH
2
Cl
2
(230 mL). The organic layer was washed with brine (20 mL), dried using
MgSO
4
, and the product purified by column chromatography (SiO
2,
hexane/EtOAc 1:1) to
afford 138 (0.96 g, 67%) as a yellow solid. Mp = 95-97
o
C.
1
H NMR (CD
3
OD): = 7.04 (d, J =
8.5 Hz, 2H), 6.74 (d, J = 8.5 Hz, 2H), 6.56 (d, J = 7.9 Hz, 1H), 6.19 (d, J = 7.9 Hz, 1H), 5.84 (s,
2H), 3.94 (s, 2H), 3.73 (brs, 1H), 2.88-3.00 (m, 2H), 2.74-2.85 (m, 2H);
13
C NMR (CD
3
OD):
= 157.32, 150.12, 147.02, 136.72, 130.80, 130.34, 123.51, 119.03, 116.66, 101.90, 98.79, 51.46,
50.09, 34.52; MS: m/z 287 (M
+
, 100%).
N-Trifluoroacetyl-N-(2`-hydroxy-3`,4`-methylenedioxyphenylmethyl)-[2-(4-
hydroxyphenyl)]ethylamine (139)
A mixture of polymer-supported DMAP (1.0 g, 3 mmol, 3 equiv.) and amine 138 (0.29 g, 1
mmol) in CH
2
Cl
2
(10 mL) was cooled to 0
o
C. Trifluoroacetic acid anhydride (0.25 g, 1.2 mmol,
1.2 equiv.) was added dropwise through a syringe. The reaction mixture was allowed to warm
to room temperature overnight. The reaction mixture was filtered, washed with MeOH (315
mL) and concentrated in vacuo. The product was purified by flash chromatography (SiO
2
,
hexane/EtOAc 1:4) to afford 139 (0.25 g, 64%) as a white solid. Mp = 185-186
o
C.
1
H NMR
(DMSO-d
6
): = 9.88 (brs, 1H), 9.22 (brs, 1H), 6.92 (m, 2H), 6.64 (m, 3H), 6.45 (m, 1H), 5.98
(d, J = 1.8 Hz, 2H), 4.58 (s, 1H), 4.30 (s, 1H), 3.33 (s, 2H), 2.67-2.83 (m, 1H), 2.55-2.66 (m,
1H).
13
C NMR (DMSO-d
6
): = 156.02, 155.94, 155.83, 155.80, 155.48, 155.34, 148.09, 148.02,
139.23, 138.90, 134.58, 134.54, 129.54, 129.50, 128.20, 127.61, 122.77, 121.17, 118.41,
118.32, 118.18, 117.70, 115.34, 115.21, 115.14, 114.58, 114.49, 100.98, 100.90, 100.27, 48.09,
47.97, 45.66, 43.87, 33.41, 31.21; MS: m/z 383 (M
+
, 100%).
54
all-Z-1,1-Dibromoheneicosa-1,6,9,12,15,18-hexaene (163)
A mixture of triphenylphosphine (806 mg, 3.1 mmol), zinc (200 mg, 3.1 mmol) and
tetrabromomethane (1.02 g, 3.1 mmol) in CH
2
Cl
2
(15 mL) was stirred at room temperature for
20 h before a solution of freshly prepared aldehyde 162 (324 mg, 1.13 mmol) in CH
2
Cl
2
(5 mL)
was added. The mixture was stirred for 2 h at room temperature. Evaporation of the solvent at
reduced pressure and filtration through a plug of SiO
2
with hexane gave the dibromide 163 (410
mg, 82%) as a colorless oil.
1
H NMR (CDCl
3
): = 6.37 (t, J = 7.2 Hz, 1H), 5.51-5.22 (m, 10H), 2.66-2.96 (m, 8H), 1.96-
2.19 (m, 6H), 1.41-1.59 (m, 2H), 0.95 (t, J = 7.5 Hz, 3H);
13
C NMR (CDCl
3
): = 138.46 (CH),
132.05 (CH), 129.18 (CH), 128.62 (CH), 128.58 (CH), 128.26 (CH), 128.24 (CH), 128.12
(CH), 128.10 (CH), 127.88 (CH), 127.01 (CH), 88.89 (C), 32.58 (CH
2
), 27.70 (CH
2
), 26.60
(CH
2
), 25.66 (CH
2
), 25.55 (CH
2
), 20.56 (CH
2
), 14.27 (CH
3
).
all-Z-Heneicosa-6,9,12,15,18-pentaen-1-yne (159)
A solution of the dibromide 163 (398 mg, 0.9 mmol) in dry ether (15 mL) was cooled to -78
o
C
before addition of methyllithium (1.6 M in ether, 1.0 mL, 1.6 mmol). The mixture was stirred
overnight at -78
o
C. A saturated aqueous solution of NH
4
Cl and hexane (20 mL) were added.
The organic layer was separated, washed with water, dried over anhydrous MgSO
4
and
evaporated under reduced pressure. The residue was purified by flash chromatography (SiO
2,
hexane/EtOAc 99:1) to yield 159 (160 mg, 63%).
all-Z-1-(2-(Methoxymethoxy)phenyl)docosa-7,10,13,16,19-pentaen-2-yn-1-ol (168)
n-BuLi (1.9 mL, 3 mmol, 1.6 M in hexane) was added to a solution of 167 (0.79 g, 2.8 mmol) in
THF (25 mL) under argon at -78 C and stirred at this temperature for 10 min. A solution of 159
(0.46 g, 2.8 mmol) in THF (15 mL) was added dropwise over 15 min. The mixture was stirred
at -78 C for 1 h before the solution was left to reach ambient temperature over 1 h. The
55
reaction was quenched by the addition of aqueous NH
4
Cl until pH = 8, and the mixture was
extracted with diethyl ether (320 mL). The combined organic layers were washed with brine
(30 mL), dried over anhydrous MgSO
4
, and the solvent removed in vacuo. The crude product
was purified by flash chromatography (SiO
2,
hexane/EtOAc 4:1) to yield 168 (0.66 g, 53%) as a
pale yellow oil;
1
H NMR (CDCl
3
): = 7.60 (dd, J = 7.6, 1.7 Hz, 1H), 7.24-7.80 (m, 1H), 7.00-
7.06 (m, 2H), 5.72-5.74 (m, 1H), 5.31-5.40 (m, 10H), 5.27, 5.24 (AB, J = 6.9 Hz, 2H), 3.50 (s,
3H), 2.76-2.83 (m, 8H), 2.29 (td, J = 7.2, 2.1 Hz, 2H), 2.15-2.21 (m, 2H), 2.07 (p, J = 7.5 Hz,
2H), 1.62 (p, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H);
13
C NMR (CDCl
3
): = 154.45 (C),
135.82 (CH), 132.03 (CH), 130.25 (C), 129.51 (CH), 129.01 (CH), 128.74 (CH), 128.30 (CH),
128.24 (CH), 128.11 (CH), 127.92 (CH), 127.87 (CH), 127.00 (CH), 122.09 (CH), 121.85
(CH), 114.55 (CH), 94.71 (CH
2
), 86.66 (C), 79.66 (C), 61.08 (CH), 56.29 (CH
3
), 28.53 (CH
2
),
26.39 (CH
2
), 25.62 (CH
2
), 25.53 (CH
2
), 20.55 (CH
2
), 18.41 (CH
2
), 14.26 (CH
3
); HRMS calcd.
for C
30
H
40
O
3
(M
+
): 448.2977, found: 448.2957.
all-Z-1-(2-(Methoxymethoxy)phenyl)docosa-7,10,13,16,19-pentaen-2-yn-1-one (169)
Manganese dioxide (1.93 g, 22.2 mmol, 20.0 equiv.) was added in small portions over 1.5 h to a
solution of alcohol 168 (0.50 g, 1.11 mmol) in CH
2
Cl
2
(15 mL). The resulting suspension was
stirred for 16 h, then filtered through a pad of celite. The celite was washed with CH
2
Cl
2
(415
mL), and the combined organics concentrated under reduced pressure to give the ketone 169 as
a pale yellow oil. The crude product was purified by flash chromatography (SiO
2,
hexane/EtOAc 4:1) to yield 169 (0.47 g, 94%) as a colorless oil;
1
H NMR (CDCl
3
): = 7.97
(dd, J = 7.8, 1.8 Hz, 1H), 7.44-7.50 (m, 1H), 7.18-7.23 (m, 1H), 7.04-7.11 (m, 1H), 7.31-7.41
(m, 10H), 7.26 (s, 2H), 3.52 (s, 3H), 2.79-2.84 (m, 8H), 2.46 (t, J = 7.2 Hz, 2H), 2.23 (q, J =
7.5 Hz, 2H), 2.07 (p, J = 7.5 Hz, 2H), 1.72 (p, J = 7.3 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H);
13
C
NMR (CDCl
3
): = 177.06 (C), 157.02 (C), 134.37 (CH), 132.40 (CH), 129.30 (CH), 128.57
(CH), 128.46 (CH), 128.37 (CH), 128.28 (CH), 128.08 (CH), 128.04 (CH), 127.93 (C), 127.86
(CH), 127.00 (CH), 125.49 (CH), 121.53 (CH), 116.17 (CH), 94.93 (CH
2
), 94.61 (C), 82.00 (C),
56.39 (CH
3
), 27.79 (CH
2
), 26.41 (CH
2
), 25.66 (CH
2
), 25.62 (CH
2
), 25.53 (CH
2
), 20.55 (CH
2
),
18.77 (CH
2
), 14.27 (CH
3
); HRMS calcd. for C
30
H
38
O
3
(M
+
): 446.2821, found: 446.2829.
56
all-Z-2-(Nonadeca-4,7,10,13,16-pentaenyl)-4H-chromen-4-one (171)
To a stirred solution of 169 (0.36 g, 0.89 mmol) in ethanol (10 mL) was added dropwise HCl
(2.5 mL, 6 M). The mixture was stirred for 3 h, then diluted with water (10 mL) and extracted
with diethyl ether (210 mL). The organic layer was washed with brine (15 mL), dried with
MgSO
4
, and evaporated under reduced pressure. The residue was purified by silica gel column
chromatography (SiO
2,
hexane/EtOAc 9:1) to yield 170 (0.24 g, 67%) as a pale yellow oil. To a
solution of 170 (0.23 g, 0.57 mmol) in acetone (10 mL) was added K
2
CO
3
(0.24 g, 1.71 mmol, 3
equiv.). The resulting suspension was stirred for 2 h at room temperature, then heated at reflux
for 1 h, then cooled down to room temperature, diluted with water (10 mL), and extracted with
diethyl ether (220 mL). The organic layer was successively washed with brine (15 mL), dried
over anhydrous MgSO
4
, and evaporated under reduced pressure. The residue was purified by
flash chromatography (SiO
2,
hexane/EtOAc 4:1) to yield 171 (0.15 g, 66%) as a pale yellow oil;
1
H NMR (CDCl
3
): = 8.18 (dd, J = 8.0, 1.5 Hz, 1H), 7.61-7.64 (m, 1H), 7.38-7.43 (m, 2H),
6.18 (s, 1H), 5.32-5.44 (m, 10H), 2.78-2.85 (m, 8H), 2.65 (t, J = 7.5 Hz, 2H), 2.17-2.23 (m,
2H), 2.10 (p, J = 7.5 Hz, 2H), 1.83 (p, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H);
13
C NMR
(CDCl
3
): = 178.31 (C), 169.41 (C), 156.51 (C), 133.43 (CH), 132.06 (CH), 129.23 (CH),
128.63 (CH), 128.60 (CH), 128.30 (CH), 128.29 (CH), 128.05 (CH), 128.02 (CH), 127.85
(CH), 127.00 (CH), 125.71 (CH), 124.92 (CH), 123.77 (C), 117.82 (CH), 109.92 (CH), 33.79
(CH
2
), 26.71 (CH
2
), 26.49 (CH
2
), 25.70 (CH
2
), 25.64 (CH
2
), 25.55 (CH
2
), 20.56 (CH
2
), 14.27
(CH
3
); MS EI m/z 402 (M
+
, 19%), 173 (100), 160 (28) HRMS calcd. for C
28
H
34
O
2
(M
+
):
402.2559, found: 402.2558.